A citation-based method for searching scientific literature

Maureen Leehey, Sheng Luo, Saloni Sharma, Anne-Marie A Wills, Jacquelyn L Bainbridge, Pei Shieen Wong, David K Simon, Jay Schneider, Yunxi Zhang, Adriana Pérez, Rohit Dhall, Chadwick W Christine, Carlos Singer, Franca Cambi, James T Boyd. Neurology 2017
Times Cited: 16







List of co-cited articles
53 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Prospective study on the components of metabolic syndrome and the incidence of Parkinson's disease.
Katri Sääksjärvi, Paul Knekt, Satu Männistö, Jukka Lyytinen, Markku Heliövaara. Parkinsonism Relat Disord 2015
38
37

Metabolic syndrome and risk of Parkinson disease: A nationwide cohort study.
Ga Eun Nam, Seon Mee Kim, Kyungdo Han, Nan Hee Kim, Hye Soo Chung, Jin Wook Kim, Byoungduck Han, Sung Jung Cho, Ji Hee Yu, Yong Gyu Park,[...]. PLoS Med 2018
61
31

Obesity, diabetes, and risk of Parkinson's disease.
Natalia Palacios, Xiang Gao, Marjorie L McCullough, Eric J Jacobs, Alpa V Patel, Tinisha Mayo, Michael A Schwarzschild, Alberto Ascherio. Mov Disord 2011
100
25

Metabolic syndrome contributes to cognitive impairment in patients with Parkinson's disease.
Zeyan Peng, Shuyang Dong, Yong Tao, Yingchao Huo, Zhenhua Zhou, Wen Huang, Hongdang Qu, Juan Liu, Yang Chen, Zhiqiang Xu,[...]. Parkinsonism Relat Disord 2018
8
50

Hypertension, hypercholesterolemia, diabetes, and risk of Parkinson disease.
Kelly Claire Simon, Honglei Chen, Michael Schwarzschild, Alberto Ascherio. Neurology 2007
166
18


Urate as a predictor of the rate of clinical decline in Parkinson disease.
Alberto Ascherio, Peter A LeWitt, Kui Xu, Shirley Eberly, Arthur Watts, Wayne R Matson, Connie Marras, Karl Kieburtz, Alice Rudolph, Mikhail B Bogdanov,[...]. Arch Neurol 2009
247
18

Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): scale presentation and clinimetric testing results.
Christopher G Goetz, Barbara C Tilley, Stephanie R Shaftman, Glenn T Stebbins, Stanley Fahn, Pablo Martinez-Martin, Werner Poewe, Cristina Sampaio, Matthew B Stern, Richard Dodel,[...]. Mov Disord 2008
18

Association of blood pressure and hypertension with the risk of Parkinson disease: the National FINRISK Study.
Chengxuan Qiu, Gang Hu, Miia Kivipelto, Tiina Laatikainen, Riitta Antikainen, Laura Fratiglioni, Pekka Jousilahti, Jaakko Tuomilehto. Hypertension 2011
96
18

The epidemiology of Parkinson's disease: risk factors and prevention.
Alberto Ascherio, Michael A Schwarzschild. Lancet Neurol 2016
765
18

Baseline predictors for progression 4 years after Parkinson's disease diagnosis in the De Novo Parkinson Cohort (DeNoPa).
Brit Mollenhauer, Johannes Zimmermann, Friederike Sixel-Döring, Niels K Focke, Tamara Wicke, Jens Ebentheuer, Martina Schaumburg, Elisabeth Lang, Tim Friede, Claudia Trenkwalder. Mov Disord 2019
83
18

Case-control study of risk of Parkinson's disease in relation to hypertension, hypercholesterolemia, and diabetes in Japan.
Yoshihiro Miyake, Keiko Tanaka, Wakaba Fukushima, Satoshi Sasaki, Chikako Kiyohara, Yoshio Tsuboi, Tatsuo Yamada, Tomoko Oeda, Takami Miki, Nobutoshi Kawamura,[...]. J Neurol Sci 2010
88
18

The role of oxidative stress in Parkinson's disease.
Vera Dias, Eunsung Junn, M Maral Mouradian. J Parkinsons Dis 2013
883
12

Regular Exercise, Quality of Life, and Mobility in Parkinson's Disease: A Longitudinal Analysis of National Parkinson Foundation Quality Improvement Initiative Data.
Miriam R Rafferty, Peter N Schmidt, Sheng T Luo, Kan Li, Connie Marras, Thomas L Davis, Mark Guttman, Fernando Cubillos, Tanya Simuni. J Parkinsons Dis 2017
67
12

Modifiable cardiovascular risk factors and axial motor impairments in Parkinson disease.
Vikas Kotagal, Roger L Albin, Martijn L T M Müller, Robert A Koeppe, Kirk A Frey, Nicolaas I Bohnen. Neurology 2014
57
12

Variable expression of Parkinson's disease: a base-line analysis of the DATATOP cohort. The Parkinson Study Group.
J Jankovic, M McDermott, J Carter, S Gauthier, C Goetz, L Golbe, S Huber, W Koller, C Olanow, I Shoulson. Neurology 1990
930
12


Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases.
A J Hughes, S E Daniel, L Kilford, A J Lees. J Neurol Neurosurg Psychiatry 1992
12

Cholesterol contributes to dopamine-neuronal loss in MPTP mouse model of Parkinson's disease: Involvement of mitochondrial dysfunctions and oxidative stress.
Rajib Paul, Amarendranath Choudhury, Sanjeev Kumar, Anirudha Giri, Rajat Sandhir, Anupom Borah. PLoS One 2017
55
12

Diabetes mellitus is independently associated with more severe cognitive impairment in Parkinson disease.
Nicolaas I Bohnen, Vikas Kotagal, Martijn L T M Müller, Robert A Koeppe, Peter J H Scott, Roger L Albin, Kirk A Frey, Myria Petrou. Parkinsonism Relat Disord 2014
50
12

Simvastatin is associated with a reduced incidence of dementia and Parkinson's disease.
Benjamin Wolozin, Stanley W Wang, Nien-Chen Li, Austin Lee, Todd A Lee, Lewis E Kazis. BMC Med 2007
272
12

The metabolic syndrome.
Robert H Eckel, Scott M Grundy, Paul Z Zimmet. Lancet 2005
12

Movement Disorder Society Task Force report on the Hoehn and Yahr staging scale: status and recommendations.
Christopher G Goetz, Werner Poewe, Olivier Rascol, Cristina Sampaio, Glenn T Stebbins, Carl Counsell, Nir Giladi, Robert G Holloway, Charity G Moore, Gregor K Wenning,[...]. Mov Disord 2004
12

Loss of substance P and inflammation precede delayed neurodegeneration in the substantia nigra after cerebral ischemia.
Beatriz Rodriguez-Grande, Victoria Blackabey, Beatrice Gittens, Emmanuel Pinteaux, Adam Denes. Brain Behav Immun 2013
46
12

Response of non-motor symptoms to levodopa in late-stage Parkinson's disease: Results of a levodopa challenge test.
Margherita Fabbri, Miguel Coelho, Leonor Correia Guedes, Ines Chendo, Catarina Sousa, Mario M Rosa, Daisy Abreu, Nilza Costa, Catarina Godinho, Angelo Antonini,[...]. Parkinsonism Relat Disord 2017
29
12

The association between lifestyle factors and Parkinson's disease progression and mortality.
Kimberly C Paul, Yu-Hsuan Chuang, I-Fan Shih, Adrienne Keener, Yvette Bordelon, Jeff M Bronstein, Beate Ritz. Mov Disord 2019
51
12

Recreational physical activity and risk of Parkinson's disease.
Evan L Thacker, Honglei Chen, Alpa V Patel, Marjorie L McCullough, Eugenia E Calle, Michael J Thun, Michael A Schwarzschild, Alberto Ascherio. Mov Disord 2008
108
12

Physical activity and risk of Parkinson's disease in the Swedish National March Cohort.
Fei Yang, Ylva Trolle Lagerros, Rino Bellocco, Hans-Olov Adami, Fang Fang, Nancy L Pedersen, Karin Wirdefeldt. Brain 2015
84
12


Inosine to increase serum and cerebrospinal fluid urate in Parkinson disease: a randomized clinical trial.
Michael A Schwarzschild, Alberto Ascherio, M Flint Beal, Merit E Cudkowicz, Gary C Curhan, Joshua M Hare, D Craig Hooper, Karl D Kieburtz, Eric A Macklin, David Oakes,[...]. JAMA Neurol 2014
162
12

Parkinson disease.
Werner Poewe, Klaus Seppi, Caroline M Tanner, Glenda M Halliday, Patrik Brundin, Jens Volkmann, Anette-Eleonore Schrag, Anthony E Lang. Nat Rev Dis Primers 2017
12

Statins, plasma cholesterol, and risk of Parkinson's disease: a prospective study.
Xuemei Huang, Alvaro Alonso, Xuguang Guo, David M Umbach, Maya L Lichtenstein, Christie M Ballantyne, Richard B Mailman, Thomas H Mosley, Honglei Chen. Mov Disord 2015
88
12

Serum urate as a predictor of clinical and radiographic progression in Parkinson disease.
Michael A Schwarzschild, Steven R Schwid, Kenneth Marek, Arthur Watts, Anthony E Lang, David Oakes, Ira Shoulson, Alberto Ascherio, Christopher Hyson, Emily Gorbold,[...]. Arch Neurol 2008
218
12

Physical activities and future risk of Parkinson disease.
Q Xu, Y Park, X Huang, A Hollenbeck, A Blair, A Schatzkin, H Chen. Neurology 2010
190
12

Type 2 diabetes and the risk of Parkinson's disease.
Gang Hu, Pekka Jousilahti, Siamak Bidel, Riitta Antikainen, Jaakko Tuomilehto. Diabetes Care 2007
292
12

Physical activity and the risk of Parkinson disease.
H Chen, S M Zhang, M A Schwarzschild, M A Hernán, A Ascherio. Neurology 2005
227
12

Smoking duration, intensity, and risk of Parkinson disease.
H Chen, X Huang, X Guo, R B Mailman, Y Park, F Kamel, D M Umbach, Q Xu, A Hollenbeck, A Schatzkin,[...]. Neurology 2010
149
12

Physical activity and risk of Parkinson's disease: a prospective cohort study.
G Logroscino, H D Sesso, R S Paffenbarger, I-M Lee. J Neurol Neurosurg Psychiatry 2006
55
12

Body mass index and the risk of Parkinson disease.
G Hu, P Jousilahti, A Nissinen, R Antikainen, M Kivipelto, J Tuomilehto. Neurology 2006
133
12

Neuroendocrine abnormalities in Parkinson's disease.
Eduardo De Pablo-Fernández, David P Breen, Pierre M Bouloux, Roger A Barker, Thomas Foltynie, Thomas T Warner. J Neurol Neurosurg Psychiatry 2017
57
12

Diabetes mellitus and Parkinson disease.
Gennaro Pagano, Sotirios Polychronis, Heather Wilson, Beniamino Giordano, Nicola Ferrara, Flavia Niccolini, Marios Politis. Neurology 2018
99
12

Update of the MDS research criteria for prodromal Parkinson's disease.
Sebastian Heinzel, Daniela Berg, Thomas Gasser, Honglei Chen, Chun Yao, Ronald B Postuma. Mov Disord 2019
222
12

Effect of High-Intensity Treadmill Exercise on Motor Symptoms in Patients With De Novo Parkinson Disease: A Phase 2 Randomized Clinical Trial.
Margaret Schenkman, Charity G Moore, Wendy M Kohrt, Deborah A Hall, Anthony Delitto, Cynthia L Comella, Deborah A Josbeno, Cory L Christiansen, Brian D Berman, Benzi M Kluger,[...]. JAMA Neurol 2018
179
12

The Global Epidemic of the Metabolic Syndrome.
Mohammad G Saklayen. Curr Hypertens Rep 2018
12

Effectiveness of home-based and remotely supervised aerobic exercise in Parkinson's disease: a double-blind, randomised controlled trial.
Nicolien M van der Kolk, Nienke M de Vries, Roy P C Kessels, Hilde Joosten, Aeilko H Zwinderman, Bart Post, Bastiaan R Bloem. Lancet Neurol 2019
158
12

Cerebral small vessel disease and incident parkinsonism: The RUN DMC study.
Helena M van der Holst, Inge W M van Uden, Anil M Tuladhar, Karlijn F de Laat, Anouk G W van Norden, David G Norris, Ewoud J van Dijk, Rianne A J Esselink, Bram Platel, Frank-Erik de Leeuw. Neurology 2015
67
12

Parkinson's disease, insulin resistance and novel agents of neuroprotection.
Iciar Aviles-Olmos, Patricia Limousin, Andrew Lees, Thomas Foltynie. Brain 2013
194
12

Risk of Parkinson disease onset in patients with diabetes: a 9-year population-based cohort study with age and sex stratifications.
Yu Sun, Ya-Hui Chang, Hua-Fen Chen, Ying-Hwa Su, Hui-Fang Su, Chung-Yi Li. Diabetes Care 2012
127
12

Brain dopamine and obesity.
G J Wang, N D Volkow, J Logan, N R Pappas, C T Wong, W Zhu, N Netusil, J S Fowler. Lancet 2001
12

Inflammation and metabolic disorders.
Gökhan S Hotamisligil. Nature 2006
12


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.